Ekadharma International Tbk (JK:EKAD) — Stock Price

Rp178.00 IDR
▼ -0.56% today

Ekadharma International Tbk (JK:EKAD) is currently trading at Rp178.00 IDR, down 0.56% today. Over the past 52 weeks, shares have ranged between Rp153.00 and Rp200.00. This page tracks Ekadharma International Tbk's live share price on the JK exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see EKAD market cap.

Ekadharma International Tbk (EKAD) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Ekadharma International Tbk's daily closing share price and trading volume on the JK exchange over the past year, giving a clear view of recent price momentum and liquidity.

Ekadharma International Tbk Income Statement — Revenue, Profit & Earnings by Year

Ekadharma International Tbk's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rp529.53 Billion Rp530.43 Billion Rp518.36 Billion Rp614.48 Billion Rp629.88 Billion
Cost of Revenue Rp382.26 Billion Rp372.44 Billion Rp346.09 Billion Rp431.98 Billion Rp414.88 Billion
Gross Profit Rp147.27 Billion Rp158.00 Billion Rp172.27 Billion Rp182.50 Billion Rp215.00 Billion
Research & Development — — — — —
SG&A Rp97.10 Billion Rp99.46 Billion Rp96.88 Billion Rp100.06 Billion Rp99.52 Billion
Total Operating Expenses Rp95.14 Billion Rp94.45 Billion Rp94.62 Billion Rp93.41 Billion Rp83.32 Billion
Operating Income Rp52.13 Billion Rp63.54 Billion Rp77.64 Billion Rp89.09 Billion Rp131.67 Billion
EBITDA Rp75.10 Billion Rp103.59 Billion Rp83.98 Billion Rp120.11 Billion Rp153.39 Billion
EBIT Rp52.13 Billion Rp83.50 Billion Rp75.17 Billion Rp99.78 Billion Rp130.12 Billion
Interest Expense Rp1.73 Billion Rp1.83 Billion Rp2.00 Billion Rp1.98 Billion Rp2.62 Billion
Income Before Tax Rp61.78 Billion Rp81.67 Billion Rp87.37 Billion Rp97.80 Billion Rp137.70 Billion
Income Tax Expense Rp9.95 Billion Rp17.06 Billion Rp13.31 Billion Rp19.83 Billion Rp29.23 Billion
Net Income Rp53.02 Billion Rp64.44 Billion Rp71.94 Billion Rp76.72 Billion Rp104.41 Billion

Ekadharma International Tbk Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Ekadharma International Tbk's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rp1.37 Trillion Rp1.29 Trillion Rp1.25 Trillion Rp1.22 Trillion Rp1.17 Trillion
Total Current Assets Rp803.79 Billion Rp754.22 Billion Rp715.05 Billion Rp669.46 Billion Rp643.77 Billion
Cash & Equivalents Rp23.42 Billion Rp18.07 Billion Rp126.64 Billion Rp392.55 Billion Rp360.66 Billion
Short-term Investments Rp462.29 Billion Rp396.24 Billion Rp356.06 Billion Rp37.85 Billion Rp24.22 Billion
Net Receivables Rp72.43 Billion Rp74.46 Billion Rp65.83 Billion Rp75.15 Billion Rp84.01 Billion
Inventory Rp184.97 Billion Rp187.24 Billion Rp157.49 Billion Rp162.47 Billion Rp168.29 Billion
Property, Plant & Equipment Rp509.94 Billion Rp483.01 Billion Rp480.00 Billion Rp487.28 Billion Rp459.57 Billion
Goodwill — — — — —
Total Liabilities Rp113.92 Billion Rp103.06 Billion Rp99.50 Billion Rp108.45 Billion Rp135.17 Billion
Total Current Liabilities Rp57.11 Billion Rp50.18 Billion Rp50.33 Billion Rp56.95 Billion Rp82.98 Billion
Long-term Debt Rp0.00 Rp0.00 Rp0.00 Rp438.76 Million Rp1.90 Billion
Net Debt Rp-57.29 Billion Rp-62.10 Billion Rp-104.99 Billion Rp-361.20 Billion Rp-310.07 Billion
Total Stockholder Equity Rp1.23 Trillion Rp1.16 Trillion Rp1.11 Trillion Rp1.08 Trillion Rp998.24 Billion
Retained Earnings Rp786.64 Billion Rp763.54 Billion Rp739.73 Billion Rp686.96 Billion Rp643.40 Billion

Ekadharma International Tbk Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Ekadharma International Tbk generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rp110.30 Billion Rp53.97 Billion Rp92.50 Billion Rp96.21 Billion Rp45.43 Billion
Capital Expenditures Rp18.52 Billion Rp16.46 Billion Rp17.35 Billion Rp9.25 Billion Rp14.15 Billion
Free Cash Flow Rp91.78 Billion Rp37.51 Billion Rp75.15 Billion Rp86.96 Billion Rp31.28 Billion
Investing Cash Flow Rp-81.69 Billion Rp-61.14 Billion Rp-316.98 Billion Rp-5.56 Billion Rp-13.78 Billion
Financing Cash Flow Rp-38.79 Billion Rp-30.10 Billion Rp-40.96 Billion Rp-60.71 Billion Rp-19.10 Billion
Dividends Paid Rp-31.16 Billion Rp-31.33 Billion Rp-31.16 Billion Rp-34.63 Billion Rp30.84 Billion
Stock-Based Compensation — — — — —
Depreciation Rp22.96 Billion Rp20.10 Billion Rp11.78 Billion Rp20.33 Billion Rp23.27 Billion
Change in Cash Rp-9.59 Billion Rp-36.82 Billion Rp-265.91 Billion Rp31.89 Billion Rp12.64 Billion

Ekadharma International Tbk Earnings History — EPS Actual vs. Analyst Estimates

Track Ekadharma International Tbk's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jun 30, 2023 3.38 — —
Mar 31, 2023 6.49 — —
Dec 31, 2022 3.18 — —
Sep 30, 2022 5.70 — —
Jun 30, 2022 4.95 — —
Mar 31, 2022 8.14 — —
Dec 31, 2021 6.94 — —
Sep 30, 2021 7.53 — —